Company
Merck & Co., Inc.
Merck is a global health care company that sells prescription medicines, including biologic therapies, vaccines and animal health products. ↗
| Headquarters | Rahway, NJ ↗ |
|---|---|
| Founded | 1891 ↗ |
| Leadership | Robert M. Davis, Chairman, CEO and President ↗ |
| Employees | 75,000 ↗ |
| Revenue | $65.0 billion (fiscal 2025) ↗ |
| Department of War obligations | $997 million in prime contracts since fiscal 2022 ↗ |
| Shares | MRK ↗ |
Products
- Keytruda is Merck's anti-PD-1 cancer therapy, given intravenously. ↗
- Gardasil and Gardasil 9 are Merck's vaccines to help prevent certain cancers and diseases caused by certain types of human papillomavirus. ↗
- Winrevair treats adults with pulmonary arterial hypertension. ↗
- Capvaxive is Merck's 21-valent pneumococcal conjugate vaccine for adults. ↗
- Welireg is Merck's oral treatment for certain von Hippel-Lindau disease-associated tumors and advanced renal cell carcinoma. ↗
- Bridion reverses two types of neuromuscular blocking agents used during surgery. ↗
- Ohtuvayre is an inhaled treatment for chronic obstructive pulmonary disease that Merck gained through Verona Pharma. ↗
- Enflonsia is a long-acting monoclonal antibody that prevents RSV lower respiratory tract disease in infants. ↗
Customers
- Federal entities including the Department of War and Veterans Affairs buy Merck medicines at statutory discounts. ↗
Acquisitions
Segments
- Merck reports two segments, Pharmaceutical and Animal Health. ↗